Latest Insider Transactions at White Mountains Insurance Group LTD (WTM)
This section provides a real-time view of insider transactions for White Mountains Insurance Group LTD (WTM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of WHITE MOUNTAINS INSURANCE GROUP LTD to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of WHITE MOUNTAINS INSURANCE GROUP LTD's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2024
|
Giles E Harrison EVP & Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+50.0%
|
-
|
|
May 23
2024
|
Mary C Choksi Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+8.81%
|
-
|
|
May 23
2024
|
Margaret Dillon Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+17.19%
|
-
|
|
May 23
2024
|
Philip A Gelston Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+9.44%
|
-
|
|
May 23
2024
|
Suzanne F. Shank Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+18.62%
|
-
|
|
May 23
2024
|
David Allen Tanner Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+7.77%
|
-
|
|
May 23
2024
|
Steven Yi Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+30.56%
|
-
|
|
May 23
2024
|
Weston M Hicks Director |
BUY
Grant, award, or other acquisition
|
Direct |
230
+8.32%
|
-
|
|
May 23
2024
|
Reid Tarlton Campbell Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+1.06%
|
-
|
|
May 23
2024
|
Peter M Carlson Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+12.71%
|
-
|
|
Mar 21
2024
|
Reid Tarlton Campbell Director |
SELL
Bona fide gift
|
Direct |
55
-0.36%
|
-
|
|
Feb 22
2024
|
Reid Tarlton Campbell Director |
BUY
Grant, award, or other acquisition
|
Direct |
45
+0.29%
|
-
|
|
Feb 22
2024
|
Michaela Hildreth MD & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
600
+23.53%
|
-
|
|
Feb 22
2024
|
Robert Lawrence Seelig EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
900
+22.22%
|
-
|
|
Feb 22
2024
|
Liam P Caffrey EVP& Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,125
+23.68%
|
-
|
|
Feb 22
2024
|
George Manning Rountree Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,800
+21.69%
|
-
|
|
Jan 01
2024
|
Robert Lawrence Seelig EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
399
-2.35%
|
$600,495
$1505.01 P/Share
|
|
Jan 01
2024
|
Reid Tarlton Campbell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
710
-4.47%
|
$1,068,550
$1505.01 P/Share
|
|
Jan 01
2024
|
George Manning Rountree Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,068
-5.85%
|
$1,607,340
$1505.01 P/Share
|
|
Jan 01
2024
|
Michaela Hildreth MD & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
261
-12.23%
|
$392,805
$1505.01 P/Share
|
|
Dec 01
2023
|
Michaela Hildreth MD & Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
100
-6.12%
|
-
|
|
Nov 17
2023
|
Weston M Hicks Director |
BUY
Open market or private purchase
|
Direct |
1,000
+8.61%
|
$1,480,000
$1480.23 P/Share
|
|
May 25
2023
|
Peter M Carlson Director |
BUY
Grant, award, or other acquisition
|
Direct |
180
+15.68%
|
-
|
|
May 25
2023
|
Margaret Dillon Director |
BUY
Grant, award, or other acquisition
|
Direct |
180
+22.22%
|
-
|
|
May 25
2023
|
Suzanne F. Shank Director |
BUY
Grant, award, or other acquisition
|
Direct |
180
+24.46%
|
-
|
|
May 25
2023
|
David Allen Tanner Director |
BUY
Grant, award, or other acquisition
|
Direct |
180
+9.12%
|
-
|
|
May 25
2023
|
Philip A Gelston Director |
BUY
Grant, award, or other acquisition
|
Direct |
180
+11.26%
|
-
|
|
May 25
2023
|
Weston M Hicks Director |
BUY
Grant, award, or other acquisition
|
Direct |
250
+16.07%
|
-
|
|
May 25
2023
|
Mary C Choksi Director |
BUY
Grant, award, or other acquisition
|
Direct |
180
+10.45%
|
-
|
|
May 25
2023
|
Steven Yi Director |
BUY
Grant, award, or other acquisition
|
Direct |
180
+46.15%
|
-
|
|
Feb 22
2023
|
Michaela Hildreth MD & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
600
+23.53%
|
-
|
|
Feb 22
2023
|
Robert Lawrence Seelig EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+23.53%
|
-
|
|
Feb 22
2023
|
Liam P Caffrey EVP& Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+33.33%
|
-
|
|
Feb 22
2023
|
George Manning Rountree Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+21.28%
|
-
|
|
Feb 22
2023
|
Weston M Hicks Director |
BUY
Grant, award, or other acquisition
|
Direct |
56
+5.04%
|
-
|
|
Jan 01
2023
|
Michaela Hildreth MD & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
176
-9.72%
|
$248,864
$1414.33 P/Share
|
|
Jan 01
2023
|
Robert Lawrence Seelig EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
359
-2.2%
|
$507,626
$1414.33 P/Share
|
|
Jan 01
2023
|
Reid Tarlton Campbell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
710
-4.8%
|
$1,003,940
$1414.33 P/Share
|
|
Jan 01
2023
|
George Manning Rountree Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,068
-6.43%
|
$1,510,152
$1414.33 P/Share
|
|
Dec 28
2022
|
Michaela Hildreth MD & Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
53
-3.62%
|
-
|
|
Dec 28
2022
|
Morgan W Davis Director |
SELL
Bona fide gift
|
Direct |
200
-2.89%
|
-
|
|
Dec 22
2022
|
Michaela Hildreth MD & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
100
-6.4%
|
$137,100
$1371.84 P/Share
|
|
Sep 20
2022
|
Morgan W Davis Director |
SELL
Open market or private sale
|
Direct |
945
-12.03%
|
$1,323,000
$1400.0 P/Share
|
|
Sep 20
2022
|
Peter M Carlson Director |
SELL
Open market or private sale
|
Direct |
200
-20.24%
|
$280,000
$1400.0 P/Share
|
|
Jun 01
2022
|
Reid Tarlton Campbell Director |
SELL
Bona fide gift
|
Direct |
100
-0.76%
|
-
|
|
May 31
2022
|
Michaela Hildreth MD & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
100
-6.01%
|
$127,000
$1270.94 P/Share
|
|
May 26
2022
|
Suzanne F. Shank Director |
BUY
Grant, award, or other acquisition
|
Direct |
225
+37.44%
|
-
|
|
May 26
2022
|
David Allen Tanner Director |
BUY
Grant, award, or other acquisition
|
Direct |
225
+12.24%
|
-
|
|
May 26
2022
|
Mary C Choksi Director |
BUY
Grant, award, or other acquisition
|
Direct |
225
+14.17%
|
-
|
|
May 26
2022
|
Peter M Carlson Director |
BUY
Grant, award, or other acquisition
|
Direct |
225
+18.55%
|
-
|